Shomura, M.; Okabe, H.; Sakakibara, M.; Sato, E.; Shiraishi, K.; Arase, Y.; Tsuruya, K.; Mishima, Y.; Hirose, S.; Kagawa, T.
Impact of Atezolizumab + Bevacizumab Therapy on Health-Related Quality of Life in Patients with Advanced Hepatocellular Carcinoma. Cancers 2024, 16, 3610.
https://doi.org/10.3390/cancers16213610
AMA Style
Shomura M, Okabe H, Sakakibara M, Sato E, Shiraishi K, Arase Y, Tsuruya K, Mishima Y, Hirose S, Kagawa T.
Impact of Atezolizumab + Bevacizumab Therapy on Health-Related Quality of Life in Patients with Advanced Hepatocellular Carcinoma. Cancers. 2024; 16(21):3610.
https://doi.org/10.3390/cancers16213610
Chicago/Turabian Style
Shomura, Masako, Haruka Okabe, Maya Sakakibara, Emi Sato, Koichi Shiraishi, Yoshitaka Arase, Kota Tsuruya, Yusuke Mishima, Shunji Hirose, and Tatehiro Kagawa.
2024. "Impact of Atezolizumab + Bevacizumab Therapy on Health-Related Quality of Life in Patients with Advanced Hepatocellular Carcinoma" Cancers 16, no. 21: 3610.
https://doi.org/10.3390/cancers16213610
APA Style
Shomura, M., Okabe, H., Sakakibara, M., Sato, E., Shiraishi, K., Arase, Y., Tsuruya, K., Mishima, Y., Hirose, S., & Kagawa, T.
(2024). Impact of Atezolizumab + Bevacizumab Therapy on Health-Related Quality of Life in Patients with Advanced Hepatocellular Carcinoma. Cancers, 16(21), 3610.
https://doi.org/10.3390/cancers16213610
